Whitepapers - Pharmaphorum

Trending

Latest White papers

in Whitepapers

Medical meetings and what HCPs want
May 15, 2018 Share
X
Medical meetings and what HCPs want
https://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/
in

Thinking niche: the challenge of pharma’s focus on small patient populations
April 24, 2018 Share
X
Thinking niche: the challenge of pharma’s focus on small patient populations
https://pharmaphorum.com/white-papers/thinking-niche-the-challenge-of-pharmas-focus-on-small-patient-populations/
in Whitepapers

Pricing and Market Access Outlook 2018
March 5, 2018 Share
X
Pricing and Market Access Outlook 2018
https://pharmaphorum.com/whitepapers/pricing-market-access-outlook-2018/
in Whitepapers

Definitive Guide to Global Transparency Regulations for the Life Sciences
November 13, 2017 Share
X
Definitive Guide to Global Transparency Regulations for the Life Sciences
https://pharmaphorum.com/whitepapers/transparency-regulations-life-sciences/
in Whitepapers

Remote HCP engagement – still a struggle for life science companies
June 1, 2018 Share
X
Remote HCP engagement – still a struggle for life science companies
https://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/
in Whitepapers

Medical meetings and what HCPs want
May 15, 2018 Share
X
Medical meetings and what HCPs want
https://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/
in Whitepapers

Pharma brand strategy: Transforming lives with rich insight
April 23, 2018 Share
X
Pharma brand strategy: Transforming lives with rich insight
https://pharmaphorum.com/whitepapers/pharma-brand-strategy-transforming-lives-with-rich-insight/
in Whitepapers

Standing on the cusp of something great: How real-world data is poised to transform cancer care
March 19, 2018 Share
X
Standing on the cusp of something great: How real-world data is poised to transform cancer care
https://pharmaphorum.com/whitepapers/standing-cusp-something-great-real-world-data-poised-transform-cancer-care/

Pharma brand strategy: Transforming lives with rich insight

The mighty power of true insight lays in its ability to turn data into a brand strategy that

X

Pharma brand strategy: Transforming lives with rich insight

https://pharmaphorum.com/whitepapers/pharma-brand-strategy-transforming-lives-with-rich-insight/

Standing on the cusp of something great: How real-world data is poised to transform cancer care

Standing on the cusp of something great: How real-world data is poised to transform cancer care

REAL-WORLD EVIDENCE IN ONCOLOGY: Towards Innovative and Affordable Patient Care How can real world evidence (RWE) improve the

X

Standing on the cusp of something great: How real-world data is poised to transform cancer care

https://pharmaphorum.com/whitepapers/standing-cusp-something-great-real-world-data-poised-transform-cancer-care/

More White papers

Pricing and Market Access Outlook 2018

Pricing and Market Access Outlook 2018

This year’s edition of Pricing and Market Access Outlook, our first as IQVIA, identifies a trend towards models

X

Pricing and Market Access Outlook 2018

https://pharmaphorum.com/whitepapers/pricing-market-access-outlook-2018/

Definitive Guide to Global Transparency Regulations for the Life Sciences

Definitive Guide to Global Transparency Regulations for the Life Sciences

In 2015, Zephyr Health released its first ‘Definitive Guide to Global Life Sciences Transparency Regulations’, outlining the

X

Definitive Guide to Global Transparency Regulations for the Life Sciences

https://pharmaphorum.com/whitepapers/transparency-regulations-life-sciences/

Seizing the potential of commercial outsourcing in the pharmaceutical sector

Seizing the potential of commercial outsourcing in the pharmaceutical sector

The power and potential of outsourcing has long been recognised as a core enabler of business growth. Yet

X

Seizing the potential of commercial outsourcing in the pharmaceutical sector

https://pharmaphorum.com/whitepapers/seizing-potential-commercial-outsourcing-pharmaceutical-sector/

Pricing and market access – facts versus fiction

Pricing and market access – facts versus fiction

‘Pricing and Market Access Outlook: 2017 Edition’ includes fresh analysis from QuintilesIMS of market forces and pricing policy based on facts and figures behind approvals of new molecular entities in 2015.

X

Pricing and market access – facts versus fiction

https://pharmaphorum.com/whitepapers/pricing-market-access-facts-versus-fiction/

Healthcare in the Digital Age

Healthcare in the Digital Age

A new whitepaper presenting analysis of exclusive M3 (EU) data, revealing the digital and technological habits and preferences of doctors and how pharma can best engage.

X

Healthcare in the Digital Age

https://pharmaphorum.com/whitepapers/healthcare-digital-age/

Planning, Executing, and Monitoring: The Three Pillars of an Effective Marketing Campaign

Planning, Executing, and Monitoring: The Three Pillars of an Effective Marketing Campaign

No longer are physicians the sole concern for the life sciences’ sales and marketing function. Today, as a

X

Planning, Executing, and Monitoring: The Three Pillars of an Effective Marketing Campaign

https://pharmaphorum.com/transversal-categories/sales-and-marketing/planning-executing-monitoring-three-pillars-effective-marketing-campaign/

Health wearables: Turning hype into value-added services

Health wearables: Turning hype into value-added services

The needs of patients continue to be weighed against the burgeoning costs of healthcare. Against this backdrop, life

X

Health wearables: Turning hype into value-added services

https://pharmaphorum.com/whitepapers/health-wearables-turning-hype-value-added-services/

The hype and the hope: The journey from consumer to medical-grade wearables

The hype and the hope: The journey from consumer to medical-grade wearables

Can medical-grade wearables provide efficient, patient-friendly, and cost-effective solutions in an ever-changing healthcare environment?

X

The hype and the hope: The journey from consumer to medical-grade wearables

https://pharmaphorum.com/whitepapers/hype-hope-journey-consumer-medical-grade-wearables/

Big data in Life Sciences: the time for strategy is now

The ability to extract insights from big data is quickly becoming a key factor for competitive advantage in

X

Big data in Life Sciences: the time for strategy is now

https://pharmaphorum.com/whitepapers/life-sciences-brands-need-big-data-strategy-now/

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

Boehringer Ingelheim UK provides an update on its patient centricity initiative ahead of a new white paper later this year.

X

Patient centricity: Identifying how Boehringer Ingelheim UK can be better

https://pharmaphorum.com/debates-insight-patients/patient-centricity-identifying-boehringer-ingelheim-uk-can-better/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com